Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, December 21, 2021
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
Oren Livnat Initiated (TARS) at Strong Buy and Held Target at $40 on, Dec 21st, 2021
Oren Livnat of HC Wainwright & Co., Initiated "Tarsus Pharmaceuticals, Inc." (TARS) at Strong Buy and Held Target at $40 on, Dec 21st, 2021.
Oren has made no other calls on TARS in the last 4 months.
There are 2 other peers that have a rating on TARS. Out of the 2 peers that are also analyzing TARS, 0 agree with Oren's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Oren
- Francois Brisebois of "Oppenheimer" Initiated at Buy and Held Target at $55 on, Tuesday, November 23rd, 2021
- Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $65 on, Friday, October 8th, 2021
